Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
Lin H, Chen ZT, Zhu XD, Li L, Qu S, Wei Z, Su F, Wei JN, Liang ZG, Mo QY, Wu JB, Meng HL.
Lin H, et al. Among authors: meng hl.
Oncotarget. 2017 Mar 21;8(38):62858-62867. doi: 10.18632/oncotarget.16399. eCollection 2017 Sep 8.
Oncotarget. 2017.
PMID: 28968954
Free PMC article.